title: [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
authors: Forschergruppe Diabetes, Krankenhaus München-Schwabing.
authors: H
authors: H
authors: Stiegler
authors: C
authors: C
authors: Diehm
authors: E
authors: E
authors: Grom
authors: M
authors: M
authors: Martin
authors: H
authors: H
authors: Mörl
authors: G
authors: G
authors: Rudofsky
authors: K H
authors: KH
authors: Vogelberg
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000527:Alprostadil / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D016523:Foot Ulcer / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged
chemical_list: D000527:Alprostadil
vernacular_title: Placebokontrollierte, doppelblinde Studie zur Wirksamkeit von i.v. Prostaglandin E1 bei Diabetikern mit AVK im Stadium IV.